Symbols

SRPT

Sarepta·NASDAQ

--(--)

SRPT Profile

Sarepta Therapeutics, Inc.

A commercial-stage biopharmaceutical company focused on unique RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities

Industry

Pharmaceutical

Established Date

07/22/1980

Listing Date

06/04/1997

Exchange

NASDAQ Stock Exchange

Full-time Employees

835

Fiscal Year Ends

12-31

Website

www.sarepta.com

Security Type

Common stock

Office address

215 First Street, Suite 415, Cambridge, MA 02142

Business

Introduction

Sarepta Therapeutics, Inc., was incorporated in Oregon on July 22, 1980. The Company is a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapies, gene therapies and other genetic therapies for the treatment of rare diseases. It has developed a variety of approved Duchenne muscular dystrophy treatments and is advancing drug candidates for other neuromuscular and skeletal diseases.